| Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation | 2021-05-25 | 2023-06-20 | |
| Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) | 2021-09-08 | 2023-06-13 | 2023-11-27 |
| Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) | 2021-04-21 | 2023-06-07 | 2024-03-22 |
| Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss | 2020-06-08 | 2023-05-31 | |
| Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa | 2020-03-18 | 2023-05-26 | 2024-05-24 |
| Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM | 2022-02-10 | 2023-05-11 | 2024-05-03 |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | 2022-04-06 | 2023-05-10 | 2023-11-22 |
| Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected | 2021-07-02 | 2023-04-21 | |
| Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension | 2019-10-07 | 2023-04-20 | |
| A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab | 2021-06-10 | 2023-04-14 | 2024-03-25 |
| Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) | 2015-06-11 | 2023-04-12 | 2023-04-19 |
| A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism | 2019-10-16 | 2023-03-28 | |
| An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study | 2020-12-16 | 2023-03-28 | 2024-02-27 |
| Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease | 2019-12-10 | 2023-03-20 | 2024-03-20 |
| Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study | 2019-09-30 | 2023-02-23 | 2024-01-10 |
| A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma | 2017-08-28 | 2023-02-13 | 2024-02-05 |
| Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C | 2019-04-16 | 2023-02-13 | 2024-02-09 |
| Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma | 2018-09-10 | 2022-12-30 | 2023-12-20 |
| Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients | 2015-07-29 | 2022-12-22 | 2023-12-16 |
| Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) | 2019-06-27 | 2022-12-14 | |
| Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations | 2020-08-19 | 2022-12-14 | 2023-11-30 |
| Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS) | 2021-09-20 | 2022-12-13 | 2024-03-11 |
| Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. | 2019-12-30 | 2022-10-27 | 2023-10-26 |
| 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer | 2021-06-15 | 2022-10-03 | |
| Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome | 2019-10-01 | 2022-09-28 | |
| Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment | 2021-01-25 | 2022-09-26 | 2023-09-19 |
| Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD | 2021-09-24 | 2022-09-15 | |
| Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) | 2019-09-25 | 2022-09-09 | 2023-08-31 |
| An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU | 2019-10-24 | 2022-09-09 | 2023-09-05 |
| Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma | 2021-09-08 | 2022-09-08 | |
| Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis. | 2017-09-12 | 2022-09-06 | 2023-09-04 |
| Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab | 2020-04-08 | 2022-09-01 | 2023-02-15 |
| Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients | 2019-07-26 | 2022-08-31 | 2023-08-31 |
| Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines | 2021-11-16 | 2022-08-09 | 2023-02-09 |
| Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia | 2021-06-30 | 2022-08-03 | |
| A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia. | 2021-06-30 | 2022-07-27 | 2023-07-14 |
| Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma | 2020-09-09 | 2022-07-12 | 2023-07-18 |
| A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation | 2020-11-30 | 2022-07-11 | 2023-07-07 |
| Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients | 2019-02-14 | 2022-07-06 | 2023-06-28 |
| Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema | 2019-05-24 | 2022-06-17 | 2023-08-04 |
| Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. | 2021-06-24 | 2022-06-02 | |
| Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis | 2020-01-29 | 2022-05-17 | 2023-05-08 |
| A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). | 2019-06-04 | 2022-04-26 | 2023-04-24 |
| A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia | 2017-09-30 | 2022-04-22 | |
| This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. | 2019-11-05 | 2022-04-20 | 2023-06-12 |
| Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C | 2021-01-29 | 2022-04-18 | 2023-04-17 |
| Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A | 2018-03-16 | 2022-03-17 | 2023-12-27 |
| Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne | 2018-09-10 | 2022-02-24 | 2023-02-21 |
| Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA | 2019-12-11 | 2022-02-17 | 2023-11-24 |
| Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) | 2020-06-04 | 2022-01-06 | 2022-11-17 |